| Zacks Company Profile for Haemonetics Corporation (HAE : NYSE) |
|
|
| |
| • Company Description |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Number of Employees: 3,023 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $52.20 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 868,343 shares |
| Shares Outstanding: 48.18 (millions) |
| Market Capitalization: $2,514.84 (millions) |
| Beta: 0.39 |
| 52 Week High: $94.99 |
| 52 Week Low: $50.68 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-0.25% |
-2.00% |
| 12 Week |
-25.49% |
-32.32% |
| Year To Date |
-33.15% |
-38.85% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Christopher A. Simon - Chief Executive Officer;President and Director
James C. D'Arecca - Executive Vice President; Chief Financial Officer
Maryanne E. Farris - Vice President; Chief Accounting Officer
Robert E. Abernathy - Director
Diane M. Bryant - Director
|
|
Peer Information
Haemonetics Corporation (BJCT)
Haemonetics Corporation (CADMQ)
Haemonetics Corporation (APNO)
Haemonetics Corporation (UPDC)
Haemonetics Corporation (IMTIQ)
Haemonetics Corporation (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 405024100
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/06/25
|
|
Share - Related Items
Shares Outstanding: 48.18
Most Recent Split Date: 12.00 (2.00:1)
Beta: 0.39
Market Capitalization: $2,514.84 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $1.12 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $4.80 |
Payout Ratio: 0.00 |
| Number of Estimates in the Fiscal Year Consensus: 5.00 |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: 11.30% |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 11/06/25 |
|
|
|
| |
